Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Rekvina Laboratories has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on 21st May, 2026; 1. To consider and approve Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Quarter and Year ended on 31st March, 2026. 2. Any other agendas as may be considered necessary with the permission of the chair. Further, in accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from April 01, 2026 till the expiry of 48 hours from the date of said financial results are made public.
The above information is a part of company’s filings submitted to BSE.
